Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intra-abdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.
von Mehren, M; Randall, RL; Benjamin, RS; Boles, S; Bui, MM; Ganjoo, KN; George, S; Gonzalez, RJ; Heslin, MJ; Kane, JM; Keedy, V; Kim, E; Koon, H; Mayerson, J; McCarter, M; McGarry, SV; Meyer, C; Morris, ZS; O'Donnell, RJ; Pappo, AS; Paz, IB; Petersen, IA; Pfeifer, JD; Riedel, RF; Ruo, B; Schuetze, S; Tap, WD; Wayne, JD; Bergman, MA; Scavone, JL
Volume / Issue
Start / End Page
Pubmed Central ID
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)